Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAIV vs TIV in breastfeeding women
NCT01181323Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2011
- Primary completion
- May 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of live attenuated influenza vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2011; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01181323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181323.